Meta-analysiscited by the Tayebat archiveabstract checked★ key study A-DRY-02 in-depth review

Large review links more dairy with slightly more prostate cancer

Dairy products, calcium, and prostate cancer risk: a systematic review and meta-analysis of cohort studies.

Overview

Aune D et al.. Am J Clin Nutr 2015 · PMID 25527754 · DOI 10.3945/ajcn.113.067157

About 7% higher risk per 400 g dairy a day and 9% per 50 g cheese a day.

Does the study support the specific claim? Partly · Methodological quality: high

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Summarise cohort studies on dairy and prostate cancer.

How was the study done?

Meta-analysis of 32 prospective studies.

How many people, animals or samples were studied?

Men in many countries.

What was actually found?

Small increases with dairy, milk, low-fat milk and cheese.

How large was the observed effect?

RR 1.07 per 400 g/d total dairy; 1.09 per 50 g/d cheese.

What do the results mean in everyday life?

A small relative risk increase; absolute risk not reported.

What are the study's limitations?

Observational; screening bias possible.

What does it say about Elawady's specific claim?

Supports a modest association; cheese not safer than milk.

Do the results apply to Germany and Europe?

Includes European data.

What can explicitly not be concluded from this study?

Causation; that cheese is safer than milk.

Scientific in-depth review

1. Full reference

Authors
Aune D, Navarro Rosenblatt DA, Chan DS, Vieira AR, Vieira R, Greenwood DC, Vatten LJ, Norat T
Journal
Am J Clin Nutr
Year
2015
Identifier
PMID 25527754 DOI 10.3945/ajcn.113.067157
Verification
verified – PubMed E-utilities efetch, 2026-10-25
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

COI not stated in PubMed record; WCRF Continuous Update Project (funding details not in abstract).

2. Research question

Are dairy and calcium intakes associated with prostate cancer risk?

3. Study design and population

Study design
Meta-analysis – Systematic review and dose-response meta-analysis of prospective studies (WCRF Continuous Update Project).
Population

Men in prospective cohorts.

Country

Multinational

Period

Search to April 2013

Sample size

32 studies

Inclusion and exclusion criteria

Prospective studies on dairy/calcium and prostate cancer.

4. Methods and endpoints

Exposure / intervention

Total dairy, milk, low-fat milk, cheese, calcium sources.

Comparator

Per dose increments

Endpoints

Total, advanced, fatal prostate cancer.

Statistical methods

Random-effects dose-response meta-analysis.

5. Actual results

Results

Total dairy RR 1.07 (1.02-1.12; n=15) per 400 g/d; total milk 1.03 (1.00-1.07) per 200 g/d; low-fat milk 1.06 (1.01-1.11) per 200 g/d; cheese 1.09 (1.02-1.18; n=11) per 50 g/d; dietary calcium 1.05 (1.02-1.09) per 400 mg/d. Dairy calcium positive, non-dairy and supplemental calcium not; supplemental calcium associated with fatal prostate cancer.

Absolute risks

not reported

Authors' conclusion

High intakes of dairy products, milk, low-fat milk, cheese and dietary/dairy calcium may increase total prostate cancer risk; other components of dairy rather than fat and calcium may be involved.

6. Strengths

  • Systematic, dose-response, prospective studies only
  • Part of WCRF CUP with standardised methods

7. Weaknesses

  • Small relative risks
  • Possible detection bias (PSA screening)
  • Heterogeneity and residual confounding
  • Overlaps with other meta-analyses (not independent confirmations)

8. Risk of bias

Orienting tool
AMSTAR 2
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Methodologically solid review; primary studies observational.

9. Assessment of the statistical interpretation

Statistically significant but small RRs; clinical significance modest.

10. Relevance to the specific claim

Core evidence for C-DRY-04; contradicts C-DRY-11 because cheese is allowed.

11. Independent contrary findings

I-DRY-11 (inverse association with colorectal cancer).

12. Transferability to Germany and Europe

Includes European cohorts.

13. Overall methodological judgement

Good-quality meta-analysis showing small positive associations; cheese not exempt.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualityhigh
Risk of biassome concerns
Precision of resultsmoderate
Directnessdirect
Reproducibilitypartly replicated
Consistency with the overall evidenceconsistent
Regional transferabilitymoderate
Adequacy of the interpretation (by the archive)essentially correct but incomplete

14. Open questions

Aggressive vs indolent disease; causal component.

15. Linked fact checks

Use by the Tayebat archive

Note: according to the archive, the studies were compiled by the archive operators. Whether Dr. Elawady himself cited this study is not established.

What the archive says about the study

Each 400 g/day of dairy raised prostate cancer risk by 7%, with cheese and low-fat milk driving similar increases.

A. What was actually studied?

Dose-response association of dairy types and calcium with prostate cancer.

B. What did the authors find?

RR 1.07 per 400 g/d dairy; cheese 1.09 per 50 g/d; low-fat milk 1.06 per 200 g/d.

C. What conclusions do the authors themselves draw?

May increase risk.

D. What does the archive derive from it?

Uses it to show dairy causes prostate cancer and supports avoiding dairy.

E. Is this derivation scientifically justified?

Figures correct; causal language ('raised') overstates; the archive mentions cheese but the system allows cheese - the study contradicts the system's own split.

Adequacy of the interpretation (by the archive)
essentially correct but incomplete